Literature DB >> 15938610

Crystal structure of Escherichia coli penicillin-binding protein 5 bound to a tripeptide boronic acid inhibitor: a role for Ser-110 in deacylation.

George Nicola1, Sridhar Peddi, Miglena Stefanova, Robert A Nicholas, William G Gutheil, Christopher Davies.   

Abstract

Penicillin-binding protein 5 (PBP 5) from Escherichia coli is a well-characterized d-alanine carboxypeptidase that serves as a prototypical enzyme to elucidate the structure, function, and catalytic mechanism of PBPs. A comprehensive understanding of the catalytic mechanism underlying d-alanine carboxypeptidation and antibiotic binding has proven elusive. In this study, we report the crystal structure at 1.6 A resolution of PBP 5 in complex with a substrate-like peptide boronic acid, which was designed to resemble the transition-state intermediate during the deacylation step of the enzyme-catalyzed reaction with peptide substrates. In the structure of the complex, the boron atom is covalently attached to Ser-44, which in turn is within hydrogen-bonding distance to Lys-47. This arrangement further supports the assignment of Lys-47 as the general base that activates Ser-44 during acylation. One of the two hydroxyls in the boronyl center (O2) is held by the oxyanion hole comprising the amides of Ser-44 and His-216, while the other hydroxyl (O3), which is analogous to the nucleophilic water for hydrolysis of the acyl-enzyme intermediate, is solvated by a water molecule that bridges to Ser-110. Lys-47 is not well-positioned to act as the catalytic base in the deacylation reaction. Instead, these data suggest a mechanism of catalysis for deacylation that uses a hydrogen-bonding network, involving Lys-213, Ser-110, and a bridging water molecule, to polarize the hydrolytic water molecule.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15938610     DOI: 10.1021/bi0473004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Crystal structures of covalent complexes of β-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity.

Authors:  George Nicola; Joshua Tomberg; R F Pratt; Robert A Nicholas; Christopher Davies
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

2.  Recognition of the β-lactam carboxylate triggers acylation of Neisseria gonorrhoeae penicillin-binding protein 2.

Authors:  Avinash Singh; Joshua Tomberg; Robert A Nicholas; Christopher Davies
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

3.  Crystal structures of penicillin-binding protein 6 from Escherichia coli.

Authors:  Yu Chen; Weilie Zhang; Qicun Shi; Dusan Hesek; Mijoon Lee; Shahriar Mobashery; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419

4.  Penicillin-binding protein 5 can form a homo-oligomeric complex in the inner membrane of Escherichia coli.

Authors:  Karl Skoog; Filippa Stenberg Bruzell; Aurélie Ducroux; Mårten Hellberg; Henrik Johansson; Janne Lehtiö; Martin Högbom; Daniel O Daley
Journal:  Protein Sci       Date:  2011-07-13       Impact factor: 6.725

5.  The role of the β5-α11 loop in the active-site dynamics of acylated penicillin-binding protein A from Mycobacterium tuberculosis.

Authors:  Alena Fedarovich; Robert A Nicholas; Christopher Davies
Journal:  J Mol Biol       Date:  2012-02-23       Impact factor: 5.469

6.  Structural analysis of the role of Pseudomonas aeruginosa penicillin-binding protein 5 in β-lactam resistance.

Authors:  Jeffrey D Smith; Malika Kumarasiri; Weilie Zhang; Dusan Hesek; Mijoon Lee; Marta Toth; Sergei Vakulenko; Jed F Fisher; Shahriar Mobashery; Yu Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

7.  Structure guided development of potent reversibly binding penicillin binding protein inhibitors.

Authors:  Esther C Y Woon; Astrid Zervosen; Eric Sauvage; Katie J Simmons; Matej Zivec; Steven R Inglis; Colin W G Fishwick; Stanislav Gobec; Paulette Charlier; André Luxen; Christopher J Schofield
Journal:  ACS Med Chem Lett       Date:  2011-01-11       Impact factor: 4.345

8.  Characterization of d-boroAla as a novel broad-spectrum antibacterial agent targeting d-Ala-d-Ala ligase.

Authors:  Sandeep Putty; Aman Rai; Darshan Jamindar; Paul Pagano; Cheryl L Quinn; Takehiko Mima; Herbert P Schweizer; William G Gutheil
Journal:  Chem Biol Drug Des       Date:  2011-09-21       Impact factor: 2.817

9.  Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors.

Authors:  Geir Kildahl-Andersen; Christian Schnaars; Anthony Prandina; Sylvie Radix; Marc Le Borgne; Lars Petter Jordheim; Tor Gjøen; Adriana Magalhães Santos Andresen; Silje Lauksund; Christopher Fröhlich; Ørjan Samuelsen; Pål Rongved; Ove Alexander Høgmoen Åstrand
Journal:  Medchemcomm       Date:  2019-03-08       Impact factor: 3.597

10.  Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity.

Authors:  Mototsugu Yamada; Takashi Watanabe; Takako Miyara; Nobuyoshi Baba; Jun Saito; Yasuo Takeuchi; Fukuichi Ohsawa
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.